Nui ka poʻe e hana i ka wā ʻoi aku ka lōʻihi o ka manawa, e ala ana i ka pō, inu a launa pū, a me ka nele o ka excising, a me ka noho lōʻihi ma ke keʻena, kahi e loaʻa ai ka BPH i ka wā ʻōpio.He mea maʻamau ka BPH, ʻike anei ʻoe i ke kumu?

BenignProstaticHyperplasia(ma hope i kapa ʻia ʻo BPH)he maʻi maʻamau i waena o nā ʻelemakule a me nā kāne ʻelemakule.ʻO ka hōʻailona maʻamau o kēia maʻi ʻo ka dysuria i waena o nā kāne waena a me nā ʻelemakule.

Ma ke ʻano o ka makahiki, ʻoi aku ka nui o nā kāne ma mua o 45 mau makahiki i ka BPH.

Ua noiʻi ʻia ʻo ka maʻi o ka BPH i 60 mau makahiki he 50%, ʻoiai ʻo ka nui o ka BPH ma 80 mau makahiki ʻoi aku ka kiʻekiʻe ma mua o 83%.

Hoʻopuni ʻia ka prostate e nā ʻiʻo, nā ʻiʻo, a me nā ʻiʻo i loko o ke kino kanaka.I kou wā ʻelemakule, ʻoi aku ka nui o kou ulu ʻana i ka prostate.

Loaʻa i ka noiʻi hoʻoponopono i kapa ʻia ʻo BPH), ʻike ʻia ka peptide molecular active liʻiliʻi i ka hoʻomaikaʻi ʻana a me ka hoʻonui ʻana i ka prostate.

ʻO ka mea nui o ka wai prostatic he protein, aʻo ka peptide e decomposed e ka protein.No laila, hiki i ka peptide ke hāʻawi pololei i ka hana o ka wai prostatic.A hiki i ka peptide ke sterilize, no laila he mea nui ia i ka prostatitis.

Aia kekahi envelope lipid ma waho o ka prostate, a ʻaʻole hiki ke komo i kekahi mau lāʻau a me nā meaʻai ma muli o ke kaumaha molekala nui. Eia nō naʻe, he liʻiliʻi ka peptide molecular active, no laila hiki iā ia ke komo maʻalahi i loko o ka prostate e hāʻawi i nā meaʻai e pono ai.

ʻO nā peptides ikaika liʻiliʻi liʻiliʻi he waiwai nui i nā ʻano amino acids mau meaʻai, hiki ke hāʻawi koke i nā meaʻai e pono ai nā kānaka, a me ka hoʻihoʻi ʻana i ka hiki ke pale aku i ka maʻi maʻi, hoʻomaikaʻi i ka pale ʻana a hoʻemi i ka hoʻi hou ʻana o ka maʻi prostatic.